| 000 | 01590 a2200421 4500 | ||
|---|---|---|---|
| 005 | 20250513152806.0 | ||
| 264 | 0 | _c19981022 | |
| 008 | 199810s 0 0 eng d | ||
| 022 | _a0022-1767 | ||
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _ade Haas, C J | |
| 245 | 0 | 0 |
_aA synthetic lipopolysaccharide-binding peptide based on amino acids 27-39 of serum amyloid P component inhibits lipopolysaccharide-induced responses in human blood. _h[electronic resource] |
| 260 |
_bJournal of immunology (Baltimore, Md. : 1950) _cOct 1998 |
||
| 300 |
_a3607-15 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAcute-Phase Proteins |
| 650 | 0 | 4 | _aAmino Acid Sequence |
| 650 | 0 | 4 | _aBinding, Competitive |
| 650 | 0 | 4 |
_aCarrier Proteins _xblood |
| 650 | 0 | 4 |
_aFluorescein-5-isothiocyanate _xanalogs & derivatives |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunization |
| 650 | 0 | 4 |
_aLipopolysaccharide Receptors _xgenetics |
| 650 | 0 | 4 |
_aLipopolysaccharides _xantagonists & inhibitors |
| 650 | 0 | 4 | _aMembrane Glycoproteins |
| 650 | 0 | 4 | _aMolecular Sequence Data |
| 650 | 0 | 4 |
_aMonocytes _xmetabolism |
| 650 | 0 | 4 |
_aNeutrophils _ximmunology |
| 650 | 0 | 4 |
_aPeptide Fragments _xblood |
| 650 | 0 | 4 |
_aProtein Binding _xdrug effects |
| 650 | 0 | 4 |
_aRecombinant Proteins _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aSerum Amyloid P-Component _xantagonists & inhibitors |
| 700 | 1 | _avan der Tol, M E | |
| 700 | 1 | _aVan Kessel, K P | |
| 700 | 1 | _aVerhoef, J | |
| 700 | 1 | _aVan Strijp, J A | |
| 773 | 0 |
_tJournal of immunology (Baltimore, Md. : 1950) _gvol. 161 _gno. 7 _gp. 3607-15 |
|
| 999 |
_c9724723 _d9724723 |
||